- Posts: 158
- Thank you received: 1
[b]iCann[/b] wrote: Impact BioMedical, Inc’s Equivir performs well against a board range of viruses in testing by its Scientific Research Partner and preparations are underway for
testing of Equivir against COVID-19
SINGAPORE, 2 March 2020 – Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) (“SeD”) wishes to announce today that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. (“GRDG”), recently conducted an additional round of testing of Equivir, a patented medical treatment and preventative drug, against a broad range of viruses. The tests results revealed that Equivir performed well against a broad range of viruses and validates the results of previous laboratory testing conducted at multiple independent facilities. These tests demonstrate the ability of Equivir to control viruses responsible for deadly infectious diseases. ..............
|Best World Int.||1.360||-|
We have 966 guests and 2 members online